Company
NEOGENOMICS INC
NeoGenomics is a clinical laboratory company that specializes in cancer genetics diagnostic testing and provides diagnostic and predictive testing services.
NEOGENOMICS INC is a publicly traded company. It trades under the ticker NEO. Leadership tracked by CEOInsider includes Warren Stone (CEO).
Leadership
Current
Recent developments
AI summary of recent coverageRecent coverage has focused on NeoGenomics announcing Warren Stone as its new chief executive officer, effective January 4, 2027, alongside related board changes. The company also reported third-quarter revenue of approximately $209 million and reiterated its financial guidance, while stock movements reflected mixed investor reaction to the leadership transition announcement.
Summarized from the headlines in the sidebar; see each source for the full story.